
AxoGen AXGN
$ 30.0
-1.3%
Quarterly report 2025-Q2
added 08-05-2025
AxoGen EV/EBITDA Ratio 2011-2025 | AXGN
Annual EV/EBITDA Ratio AxoGen
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -19.1 | -34.1 | -16.5 | -29.5 | -123 | -40.2 | -14.3 | -8.11 | -6.11 | -6.21 | -1.32 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.32 | -123 | -27.1 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Abiomed
ABMD
|
-0.204 | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Apyx Medical Corporation
APYX
|
-29.2 | $ 3.82 | -1.04 % | $ 132 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
34.5 | $ 307.08 | -0.33 % | $ 8.66 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-2.13 | $ 45.69 | 1.24 % | $ 6.81 K | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Abbott Laboratories
ABT
|
20.3 | $ 128.67 | 2.55 % | $ 224 B | ||
|
Boston Scientific Corporation
BSX
|
25.2 | $ 91.95 | -0.67 % | $ 135 B | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.18 | 10.56 % | $ 119 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Cognyte Software Ltd.
CGNT
|
23 | $ 9.58 | -2.84 % | $ 688 M | ||
|
InMode Ltd.
INMD
|
23.3 | $ 14.35 | -1.1 % | $ 1.14 B | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 0.99 | 7.52 % | $ 16 M | ||
|
IRadimed Corporation
IRMD
|
46 | $ 96.99 | 0.79 % | $ 1.23 B | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
48.9 | $ 163.04 | -1.44 % | $ 12.2 B | ||
|
Accuray Incorporated
ARAY
|
19.9 | $ 1.04 | -2.06 % | $ 107 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 12.5 | -1.66 % | $ 338 M | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 14.9 | 0.99 % | $ 97.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 40.3 | -1.29 % | $ 1.24 B | ||
|
LivaNova PLC
LIVN
|
215 | $ 63.28 | 0.84 % | $ 3.43 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 17.83 | 1.31 % | $ 411 M | ||
|
Globus Medical
GMED
|
27.6 | $ 86.73 | 0.05 % | $ 11.8 B | ||
|
LENSAR
LNSR
|
-1.48 | $ 11.51 | -0.04 % | $ 133 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 13.51 | 0.67 % | $ 1.04 B | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 19.79 | -0.85 % | $ 2.83 B | ||
|
Aethlon Medical
AEMD
|
-0.459 | $ 3.07 | -9.71 % | $ 4.79 M | ||
|
Establishment Labs Holdings
ESTA
|
-68.6 | $ 72.39 | -0.17 % | $ 2.04 B |